Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines
- PMID: 33153908
- PMCID: PMC7561287
- DOI: 10.1016/j.it.2020.10.005
Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines
Abstract
The innate immune system acts as the first line of defense against pathogens, including coronaviruses (CoVs). Severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV are epidemic zoonotic CoVs that emerged at the beginning of the 21st century. The recently emerged virus SARS-CoV-2 is a novel strain of CoV that has caused the coronavirus 2019 (COVID-19) pandemic. Scientific advancements made by studying the SARS-CoV and MERS-CoV outbreaks have provided a foundation for understanding pathogenesis and innate immunity against SARS-CoV-2. In this review, we focus on our present understanding of innate immune responses, inflammasome activation, inflammatory cell death pathways, and cytokine secretion during SARS-CoV, MERS-CoV, and SARS-CoV-2 infection. We also discuss how the pathogenesis of these viruses influences these biological processes.
Keywords: COVID-19; MERS-CoV; MHV; PANoptosis; PANoptosome; RNA virus; SARS-CoV; SARS-CoV-2; cell death; coronavirus; cytokines; inflammasome; inflammation; innate immunity.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Figures



Similar articles
-
Inflammasomes and SARS-CoV-2 Infection.Viruses. 2021 Dec 14;13(12):2513. doi: 10.3390/v13122513. Viruses. 2021. PMID: 34960782 Free PMC article. Review.
-
Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.J Interferon Cytokine Res. 2021 Jun;41(6):205-219. doi: 10.1089/jir.2021.0060. J Interferon Cytokine Res. 2021. PMID: 34161170 Free PMC article. Review.
-
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.Annu Rev Immunol. 2024 Jun;42(1):615-645. doi: 10.1146/annurev-immunol-083122-043545. Annu Rev Immunol. 2024. PMID: 38941608 Free PMC article. Review.
-
Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats.J Leukoc Biol. 2022 Feb;111(2):497-508. doi: 10.1002/JLB.4COVHR0221-093RR. Epub 2021 May 31. J Leukoc Biol. 2022. PMID: 34057760 Free PMC article. Review.
-
Innate immunity: the first line of defense against SARS-CoV-2.Nat Immunol. 2022 Feb;23(2):165-176. doi: 10.1038/s41590-021-01091-0. Epub 2022 Feb 1. Nat Immunol. 2022. PMID: 35105981 Free PMC article. Review.
Cited by
-
Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?Int J Mol Sci. 2022 Nov 12;23(22):13951. doi: 10.3390/ijms232213951. Int J Mol Sci. 2022. PMID: 36430430 Free PMC article. Review.
-
Infection-induced inflammation from specific inborn errors of immunity to COVID-19.FEBS J. 2021 Sep;288(17):5021-5041. doi: 10.1111/febs.15961. Epub 2021 May 20. FEBS J. 2021. PMID: 33971084 Free PMC article. Review.
-
Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19.Cell Discov. 2021 Jun 8;7(1):42. doi: 10.1038/s41421-021-00274-1. Cell Discov. 2021. PMID: 34103487 Free PMC article.
-
In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19.Front Pharmacol. 2021 Feb 26;12:598925. doi: 10.3389/fphar.2021.598925. eCollection 2021. Front Pharmacol. 2021. PMID: 33716737 Free PMC article.
-
SARS-CoV-2 Nonstructural Proteins 1 and 13 Suppress Caspase-1 and the NLRP3 Inflammasome Activation.Microorganisms. 2021 Feb 26;9(3):494. doi: 10.3390/microorganisms9030494. Microorganisms. 2021. PMID: 33652815 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous